Apyx Medical (APYX) Cash from Investing Activities Growth (1y) (2012 - 2026)
Apyx Medical (APYX) Cash from Investing Activities Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -87.14% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -208.79% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -397.90% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -514.25% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -187.82% |
| 10 | Apyx Medical | 170.16 Mn | 139.02 Mn | 7.93 Mn | -9.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.09% |
| Dec 31, 2025 | -12.24% |
| Sep 30, 2025 | -239.22% |
| Jun 30, 2025 | 8.30% |
| Mar 31, 2025 | -57.14% |
| Dec 31, 2024 | -163.44% |
| Sep 30, 2024 | 12.07% |
| Jun 30, 2024 | -104.06% |
| Mar 31, 2024 | 68.18% |
| Dec 31, 2023 | 34.51% |
| Sep 30, 2023 | 7.45% |
| Jun 30, 2023 | 1,873.32% |
| Mar 31, 2023 | 60.57% |
| Dec 31, 2022 | 57.23% |
| Sep 30, 2022 | -10.59% |
| Jun 30, 2022 | -1,282.76% |
| Mar 31, 2022 | -45.31% |
| Dec 31, 2021 | 14.43% |
| Sep 30, 2021 | -1,788.89% |
| Jun 30, 2021 | 69.15% |